Population-specific genetic differences of acute coronary syndrome in Han and Uyghur Chinese
Hongmei Lai1,2, Jinhang Zhu3, Jing Tao1,2
1The Cardiac and Panvascular Medicine Diagnosis and Treatment Center, People's Hospital of Xinjiang Uyghur Autonomous Region, Xinjiang, China.
Insights
Genetic variations in acute coronary syndrome (ACS) differ between Han and Uyghur Chinese populations. These findings support ethnicity-specific precision medicine for cardiovascular disease risk stratification and treatment.
Area of Science:
- Cardiovascular Genetics
- Precision Medicine
- Population Health
Background:
- Acute coronary syndrome (ACS) presents diverse clinical features, requiring personalized treatment.
- Understanding ethnic-specific genetic variations is crucial for tailored cardiovascular therapies.
Purpose of the Study:
- To investigate genetic polymorphisms associated with ACS subtypes in Han and Uyghur Chinese populations.
- To identify ethnic-specific genetic markers for precision medicine in ACS.
Main Methods:
- Enrolled 985 ACS patients (668 Han, 317 Uyghur Chinese) across different ACS subtypes.
- Analyzed clinical characteristics and 66 genetic polymorphisms.
- Performed statistical analyses to identify ethnic and subtype-specific genetic differences.
Main Results:
- Significant clinical and genetic differences were found between ACS subtypes and ethnic groups.
- Identified specific gene polymorphisms (e.g., CYP2D6, PTGER3 in Han; ACY3, CACNA1C, CYP2C9, CYP2C19, CYP4F2, VKORC1 in Uyghur) associated with ACS.
- Developed predictive models with higher AUC in Uyghur (0.832) than Han (0.674) patients, indicating population-specific genetic marker efficacy.
Conclusions:
- ACS exhibits distinct genetic architectures between Han and Uyghur Chinese populations.
- Highlights the need for population-specific strategies in ACS risk stratification and treatment.
- Identified genetic markers and models may advance ethnicity-specific cardiovascular risk assessment.
Background:
Acute coronary syndrome (ACS) is a critical cardiovascular condition with diverse clinical presentations, necessitating personalized therapeutic approaches. This study explores the genetic variation associated with ACS subtypes in the Han and Uyghur Chinese populations to support the development of precision medicine approaches tailored to ethnic-specific genetic backgrounds.
Methods:
A total of 985 ACS patients (668 Han and 317 Uyghur Chinese) representing different ACS subtypes were enrolled. Clinical characteristics and 66 genetic polymorphisms were analyzed. Statistical analyses were conducted to identify differences in genetic variants and clinical features across ACS subtypes and ethnic groups.
Results:
Significant clinical and genetic differences were observed between ACS subtypes and between ethnic groups. In the Han population, polymorphisms in CYP2D6 and PTGER3 were significantly associated with ACS subtypes (p ≤ 0.05). In the Uyghur population, six genes-ACY3, CACNA1C, CYP2C9, CYP2C19, CYP4F2, and VKORC1-showed significant associations (p ≤ 0.05). These findings indicate distinct genetic landscapes across the two ethnic groups. Furthermore, population-specific associations between genetic variants and artery narrowing were identified. Predictive models integrating clinical and genetic features achieved an area under the curve (AUC) of 0.832 [95% confidence intervals (CI): 0.774-0.889] in Uyghur patients and 0.674 (95% CI: 0.626-0.722) in Han patients, indicating a higher internal AUC of these genetic markers in the Uyghur population.
Conclusion:
This study highlights ethnic differences in the genetic architecture of ACS. The result also underscores the need for population-specific strategies in risk stratification and treatment. The identified genetic markers and predictive models may guide future research on ethnicity-specific risk stratification.
More Related Videos
07:35Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Single Nucleotide Polymorphisms-SNPs
Acute Coronary Syndrome V: Nursing Management
